Chien-Hung Gow Jin-Yuan Shih Yih-Leong Chang Chong-Jen Yu
10.1371/journal.pmed.0020269
PLoS Med
2005 Sep;2(9):e269.
CC BY
https://pubmed.ncbi.nlm.nih.gov/16173832/
Adenocarcinoma / genetics Drug Resistance, Neoplasm / genetics ErbB Receptors / genetics Lung Neoplasms / genetics
Adenocarcinoma / genetics Drug Resistance, Neoplasm / genetics ErbB Receptors / genetics Lung Neoplasms / genetics Case Reports Letter Comment Adenocarcinoma / drug therapy Drug Administration Schedule ErbB Receptors / antagonists & inhibitors Female Gefitinib Humans Lung Neoplasms / drug therapy Middle Aged Mutation Protein Kinase Inhibitors / administration & dosage Protein Kinase Inhibitors / therapeutic use Quinazolines / administration & dosage Quinazolines / therapeutic use Protein Kinase Inhibitors Quinazolines ErbB Receptors Gefitinib
PMC1236792
16173832
Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R
2005